Vernon E. Walker

4.0k total citations
99 papers, 3.3k citations indexed

About

Vernon E. Walker is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Vernon E. Walker has authored 99 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cancer Research, 37 papers in Molecular Biology and 29 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Vernon E. Walker's work include Carcinogens and Genotoxicity Assessment (54 papers), DNA Repair Mechanisms (23 papers) and Effects and risks of endocrine disrupting chemicals (21 papers). Vernon E. Walker is often cited by papers focused on Carcinogens and Genotoxicity Assessment (54 papers), DNA Repair Mechanisms (23 papers) and Effects and risks of endocrine disrupting chemicals (21 papers). Vernon E. Walker collaborates with scholars based in United States, Canada and United Kingdom. Vernon E. Walker's co-authors include James A. Swenberg, Dale M. Walker, Patricia B. Upton, Miriam C. Poirier, Natalia Tretyakova, Alex M. Thomson, Diana M. Flynn, Ofelia A. Olivero, Quanxin Meng and Jun Nakamura and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Vernon E. Walker

98 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vernon E. Walker United States 34 1.5k 1.5k 693 483 291 99 3.3k
Vikas Misra United States 27 1.9k 1.2× 417 0.3× 189 0.3× 383 0.8× 72 0.2× 41 3.3k
Leonarda Troiano Italy 35 1.5k 1.0× 148 0.1× 111 0.2× 301 0.6× 111 0.4× 72 3.3k
Charles L. Litterst United States 27 731 0.5× 296 0.2× 166 0.2× 173 0.4× 78 0.3× 71 2.6k
Stephen D. Fox United States 24 1.7k 1.1× 574 0.4× 288 0.4× 98 0.2× 42 0.1× 56 2.7k
Maryse Guérin France 37 933 0.6× 806 0.5× 56 0.1× 110 0.2× 62 0.2× 123 4.1k
Hiroshi Kondoh Japan 26 2.2k 1.4× 870 0.6× 75 0.1× 79 0.2× 109 0.4× 42 3.7k
Louis E. King United States 23 874 0.6× 161 0.1× 562 0.8× 102 0.2× 312 1.1× 33 3.0k
Francis J. Chrest United States 31 1.9k 1.2× 794 0.5× 48 0.1× 73 0.2× 59 0.2× 57 3.5k
Xavier Collet France 39 1.9k 1.2× 457 0.3× 24 0.0× 146 0.3× 78 0.3× 90 4.6k
C. Di Ilio Italy 26 1.4k 0.9× 314 0.2× 75 0.1× 99 0.2× 88 0.3× 84 2.6k

Countries citing papers authored by Vernon E. Walker

Since Specialization
Citations

This map shows the geographic impact of Vernon E. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vernon E. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vernon E. Walker more than expected).

Fields of papers citing papers by Vernon E. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vernon E. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vernon E. Walker. The network helps show where Vernon E. Walker may publish in the future.

Co-authorship network of co-authors of Vernon E. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Vernon E. Walker. A scholar is included among the top collaborators of Vernon E. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vernon E. Walker. Vernon E. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, Dale M., et al.. (2023). WR1065 conjugated to thiol-PEG polymers as novel anticancer prodrugs: broad spectrum efficacy, synergism, and drug resistance reversal. Frontiers in Oncology. 13. 1212604–1212604. 1 indexed citations
2.
Kotapati, Srikanth, Dewakar Sangaraju, Lance Hallberg, et al.. (2014). Bis-butanediol-mercapturic acid (bis-BDMA) as a urinary biomarker of metabolic activation of butadiene to its ultimate carcinogenic species. Carcinogenesis. 35(6). 1371–1378. 18 indexed citations
3.
Goggin, Melissa, James A. Swenberg, Vernon E. Walker, & Natalia Tretyakova. (2009). Molecular Dosimetry of 1,2,3,4-Diepoxybutane–Induced DNA-DNA Cross-Links in B6C3F1 Mice and F344 Rats Exposed to 1,3-Butadiene by Inhalation. Cancer Research. 69(6). 2479–2486. 59 indexed citations
4.
Torres, Salina, et al.. (2007). Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells. Environmental and Molecular Mutagenesis. 48(3-4). 239–247. 24 indexed citations
5.
O’Neill, John P., Terri Messier, Vernon E. Walker, et al.. (2006). V(D)J Recombinase-Mediated Processing of Coding Junctions at Cryptic Recombination Signal Sequences in Peripheral T Cells during Human Development. The Journal of Immunology. 177(8). 5393–5404. 12 indexed citations
6.
Boysen, Gunnar, Nadia I. Georgieva, Patricia B. Upton, Vernon E. Walker, & James A. Swenberg. (2006). N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides. Chemico-Biological Interactions. 166(1-3). 84–92. 35 indexed citations
7.
Powley, Mark W., Yanbin Li, Patricia B. Upton, Vernon E. Walker, & James A. Swenberg. (2005). Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol. Carcinogenesis. 26(9). 1573–1580. 24 indexed citations
8.
Boysen, Gunnar, Nadia I. Georgieva, Patricia B. Upton, et al.. (2004). Analysis of Diepoxide-Specific Cyclic N -Terminal Globin Adducts in Mice and Rats after Inhalation Exposure to 1,3-Butadiene. Cancer Research. 64(23). 8517–8520. 49 indexed citations
9.
Walker, Dale M., Steven K. Seilkop, Bobby R. Scott, & Vernon E. Walker. (2004). Hprt mutant frequencies in splenic T‐cells of male F344 rats exposed by inhalation to propylene. Environmental and Molecular Mutagenesis. 43(4). 265–272. 7 indexed citations
10.
Meng, Quanxin, et al.. (2004). Characterization ofHprtmutations in cDNA and genomic DNA of T‐cell mutants from control and 1,3‐butadiene‐exposed male B6C3F1 mice and F344 rats. Environmental and Molecular Mutagenesis. 43(2). 75–92. 17 indexed citations
11.
Divi, Rao L., Vernon E. Walker, Nancy A. Wade, et al.. (2004). Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS. 18(7). 1013–1021. 71 indexed citations
12.
Poirier, Miriam C., Rao L. Divi, Lena Al‐Harthi, et al.. (2003). Long-Term Mitochondrial Toxicity in HIV-Uninfected Infants Born to HIV-Infected Mothers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(2). 175–183. 149 indexed citations
13.
Bauer, Michael, et al.. (2001). Transplacental mutagenicity of N‐ethyl‐N‐nitrosourea at the hprt locus in T‐lymphocytes of exposed B6C3F1 mice. Environmental and Molecular Mutagenesis. 38(1). 30–37. 11 indexed citations
14.
Meng, Quanxin, Rogene F. Henderson, Dale M. Walker, et al.. (2001). Mutagenicity at the Hprt locus in T cells of female mice following inhalation exposures to low levels of 1,3-butadiene. Chemico-Biological Interactions. 135-136. 343–361. 16 indexed citations
15.
Meng, Quanxin, Navjot Singh, Robert H. Heflich, Michael Bauer, & Vernon E. Walker. (2000). Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 464(2). 169–184. 28 indexed citations
16.
Walker, Vernon E., Irene M. Jones, Tawni L. Crippen, et al.. (1999). Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 431(2). 371–388. 33 indexed citations
17.
Walker, Vernon E., et al.. (1997). In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 392(3). 211–222. 37 indexed citations
18.
Fedtke, N., Joyce A. Boucheron, Vernon E. Walker, & James A. Swenberg. (1990). Vinyl chloride-induced DNA adducts II: Formating and persistence of 7-(2'oxoethyl)guanine and N2 ,3 ethenoguanine in rat tissue DNA. Carcinogenesis. 11(8). 1287–1292. 87 indexed citations
19.
Fedtke, N., Vernon E. Walker, & James A. Swenberg. (1989). Determination of 7-(2-Oxoethyl)guanine and N2,3-Ethenoguanine in DNA Hydrolysates by HPLC. Archives of toxicology. Supplement. 13. 214–218. 14 indexed citations
20.
Thomson, Alex M., Vernon E. Walker, & Diana M. Flynn. (1989). Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature. 338(6214). 422–424. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026